Khiron Life Sciences Corp.
KHRNF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -24.3% | -3.7% | 27.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 48.8% | 52.6% | 32.2% | 32.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -85.3% | -56.3% | -99.3% | -81.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -105.6% | -48.5% | -116.6% | -536.3% |
| EPS Diluted | -0.017 | -0.012 | -0.03 | -0.11 |
| % Growth | -44% | 61.6% | 72.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |